Fluorescent dyes and related methods

US9410947B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9410947-B2
Application numberUS-201314418303-A
CountryUS
Kind codeB2
Filing dateAug 6, 2013
Priority dateAug 7, 2012
Publication dateAug 9, 2016
Grant dateAug 9, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Fluorescent dyes with affinity for nucleic acids and related methods are provided. Dielectric or semiconducting films including fluorescent dyes with affinity for nucleic acids and related methods are also provided. Coumarin-based surfactants conjugated to the fluorescent dyes with affinity for nucleic acids and related methods are provided. Fluorescent compounds capable of interacting with DNA can be used for a variety of applications.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound having the general formula (I): wherein each of R 1 and R 2 are independently selected from the group consisting of hydrogen, substituted or unsubstituted, methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, substituted butyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, or wherein R 1 and R 2 are joined together to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; each of R 3A , R 3B , R 3C , R 3D , R 3E and R 3F are independently selected from the group consisting of hydrogen, a halide, —OH, —NH 2 , —CN, —SH, —NO 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; R 4A and R 4D are hydrogen; each of R 4B and R 4C are independently hydrogen or —CN; and salts and isomers thereof; or the general formula (II): wherein each of R 1 and R 2 are independently selected from the group consisting of hydrogen, substituted or unsubstituted methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, substituted butyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, or wherein R 1 and R 2 are joined together to form substituted or unsubstituted heterocycloalkyl, or substituted or unsubstituted heteroaryl; each of R 3A , R 3B , R 3C , R 3D , R 3E and R 3F are independently selected from the group consisting of hydrogen, a halide, —OH, —NH 2 , —CN, —SH, —NO 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; R 4A , R 4D are hydrogen; each of R 4B and R 4C are independently hydrogen or —CN; R 5 is selected from the group consisting of a halide, —CN, —NO 2 , fluorinated alkyl, fluorinated heteroalkyl, fluorinated acyl, fluorinated alkoxy, fluorinated cycloalkyl, fluorinated heterocycloalkyl, fluorinated aryl, fluorinated heteroaryl, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted acyl, unsubstituted alkoxy, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, and unsubstituted heteroaryl; and salts and isomers thereof; provided that when R 4A , R 4B , R 4C and R 4D are hydrogen, R 1 and R 2 are not phenyl. 2. The compound of claim 1 , wherein each of R 1 and R 2 are independently selected from substituted or unsubstituted methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, substituted butyl, unsubstituted acyl, substituted or unsubstituted alkoxy, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, substituted or unsubstituted aryl, and unsubstituted heteroaryl. 3. The compound of claim 1 , wherein each of R 1 and R 2 are unsubstituted methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, substituted butyl, or wherein R 1 and R 2 are joined together to form a substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. 4. The compound of claim 1 , wherein R 5 is unsubstituted C 1 -C 10 alkyl. 5. The compound of claim 1 , wherein R 5 is selected from the group consisting of substituted or unsubstituted alkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, and substituted or unsubstituted aryl. 6. The compound of claim 1 , wherein the compound of general formula (II) comprises a salt including a counterion selected from the group consisting of a halide, acetate, halogen-substituted acetate and tosylate. 7. The compound of claim 1 , wherein the compound of general formula (II) comprises a salt including a counterion selected from the group consisting of a halide, acetate and trifluoroacetate. 8. The compound of claim 1 , wherein the compound of general formula (II) comprises a salt including a counterion selected from the group consisting of I − , O(C═O)CH 3 − , and O(C═O)CF 3 − . 9. The compound of claim 1 , having any one of the following formulas: 10. A method for detecting a nucleic acid molecule in a sample, the method comprising: combining the sample and a compound to form a complex including the compound and the nucleic acid molecule; and detecting the nucleic acid molecule the complex including the compound and the nucleic acid molecule, thereby detecting the nucleic acid molecule, wherein the compound has the genera formula (I): wherein each of R 1 and R 2 are independently selected from the group consisting of hydrogen, substituted or unsubstituted methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, substituted butyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, or wherein R 1 and R 2 are joined together to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; each of R 3A , R 3B , R 3C , R 3D , R 3E and R 3F are independently selected from the group consisting of hydrogen, a halide, —OH, —NH 2 , —CN, —SH, —NO 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; R 4A , R 4D are hydrogen; each of R 4B and R 4C are independently hydrogen or —CN; and salts and isomers thereof; or the general formula (II): wherein each of R 1 and R 2 are independently selected from the group consisting of hydrogen, substituted or unsubstituted methyl

Assignees

Inventors

Classifications

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom · CPC title

  • Coumarine dyes · CPC title

  • with hetero atoms directly attached to the ring nitrogen atom · CPC title

  • Stain compositions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9410947B2 cover?
Fluorescent dyes with affinity for nucleic acids and related methods are provided. Dielectric or semiconducting films including fluorescent dyes with affinity for nucleic acids and related methods are also provided. Coumarin-based surfactants conjugated to the fluorescent dyes with affinity for nucleic acids and related methods are provided. Fluorescent compounds capable of interacting with DNA…
Who is the assignee on this patent?
Univ Washington Through Its Center For Commercialization
What technology area does this patent fall under?
Primary CPC classification C09B57/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).